◀ Back to TGFB3

IL13 — TGFB3

Text-mined interactions from Literome

Lee et al., J Exp Med 2001 (Pulmonary Fibrosis) : We hypothesized that the fibrogenic effects of IL-13 are mediated by transforming growth factor ( TGF ) -beta
Bry et al., Am J Obstet Gynecol 1992 (Obstetric Labor, Premature) : Human amnion cells in monolayer culture were treated with interleukin-1 , tumor necrosis factor, or vehicle in the presence or absence of transforming growth factor-beta
Finotto et al., Int Immunol 2005 (Asthma) : IL-13 blockade also led to reduced eosinophilia and decreased vimentin, transforming growth factor beta ( TGF-beta ) and alpha smooth muscle actin ( alphaSMA ) levels
Roberts et al., Mol Hum Reprod 2005 : We also showed that tumour necrosis factor-alpha ( TNF-alpha ; 10 and 25 ng/ml ) and transforming growth factor-beta ( TGF-beta; 1 and 5 ng/ml ), cytokines with inflammatory and immune regulatory functions in a cell- and dose dependent manner regulate the expression of IL-13 and IL-15 ( P < 0.05 )
Layh-Schmitt et al., Curr Opin Rheumatol 2008 (Spondylarthropathies) : In mice, transforming growth factor-beta and interleukin-6 are critical, whereas interleukin-23 is more important at later stages promoting interleukin-17 production
Shimamura et al., Clin Cancer Res 2010 (Adenocarcinoma...) : IL-13 causes transforming growth factor-beta activation via AP-1 pathway, which may cause tumor induced immunosuppression in the host
Marth et al., Eur J Immunol 1997 : Regulation of transforming growth factor-beta production by interleukin-12
Fulton et al., J Infect Dis 1998 : Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta , tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra